Last Updated:

DML-A
2019
*3257451850194* >

KIT 32574518 5 01 94
CAP # 7230938 - 01 SEQ # 01
Page 1
Results are due no later than midnight, Central Time: Products: DML
ST LUKES MEDICAL CENTER
ROMMEL SACEDA RMT(HEW)
May 8, 2019 TEL# 63-002-7256716 FAX# 63-002-7241562

Enter and approve results online at cap.org.

Class I and II HLA Molecular Typing Survey Result Form

Important
Changes for this mailing are noted in the Important: Before You Begin section of the kit instructions.
Corrections can be made to this result form at any time prior to the due date. For results that are approved online, corrections must also be
done online. Faxed or mailed corrections will not be accepted.
© CAP 2019

Methods and Specimen Information

All Loci
Specific typing method(s) routinely used for testing of these specimens: (Select all that apply.)
010 71 Real Time PCR
72 Sequence Specific Oligonucleotide Probe (SSOP) forward
73 Sequence Specific Oligonucleotide Probe (SSOP) reverse
45 Sequence Specific Primers (SSP)
58 Sequencing, Next Generation
47 Sequencing, Sanger
01 Other, specify in final section

Reporting Results
Your HLA nomenclature sequence should be entered into the reporting boxes like the following:
010
A*01:52 should be entered as: 0 1 :5 2
If you identify a new high resolution type not included in the master list, use the 4-digit code 00:00 (eg, DRB1*00:00 for a new DRB1 allele),
and explain your findings in the “Additional Comments” section (eg,“this type differs from…by substitution of…at nucleotide…”).

Or

Similarly, if you identify a non-expressed (eg, A*02:43N) or alternately-expressed (eg, A*30:14L or B*35:65Q) allele, enter your result as
00:00/00:000 and list the actual allele in the "Additional Comments" section.

29713
Customer Contact Center 800-323-4040 option 1 (domestic)
or 001-847-832-7000 option 1 (international) APN1
Save Close > >|